Zhao Shidou, Li Guangyu, Dalgleish Raymond, Vujovic Svetlana, Jiao Xue, Li Jin, Simpson Joe Leigh, Qin Yingying, Ivanisevic Maja, Ivovic Miomira, Tancic Milina, Al-Azzawi Farook, Chen Zi-Jiang
Center for Reproductive Medicine, Provincial Hospital Affiliated to Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key Laboratory for Reproductive Endocrinology of Ministry of Education, Shandong Provincial Key Laboratory of Reproductive Medicine, Jinan, People's Republic of China.
Department of Genetics, University of Leicester, Leicester, United Kingdom.
Fertil Steril. 2015 Feb;103(2):548-53.e5. doi: 10.1016/j.fertnstert.2014.11.011. Epub 2014 Dec 17.
To investigate whether gene variants of SOHLH1 exist in Chinese and Serbian patients with primary ovarian insufficiency (POI).
Case-control genetic study.
University hospitals.
PATIENT(S): A total of 364 Han Chinese and 197 Serbian women with nonsyndromic POI and ethnically matched controls.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): SOHLH1 gene sequencing.
RESULT(S): We found 10 novel heterozygous variants in our cohorts of 561 women with POI but none in the 600 ethnically matched controls. Statistical and bioinformatic analyses indicated that three of the eight variants in Chinese POI cases are potentially disease causing. They comprise two missense variants (p.Ser317Phe and p.Glu376Lys) that might each change activity of the SOHLH1 protein as a transcription factor and one variant (c.*118C>T) located in the 3' untranslated region of the SOHLH1 gene, which might generate a new binding site for the microRNA hsa-miR-888-5p. Of the two variants in the Serbian POI cases, both were synonymous, and no missense variant was identified. The allele frequencies of some known single-nucleotide polymorphisms were statistically significantly different between patients and controls in both the Chinese and Serbian groups.
CONCLUSION(S): Our results suggest that SOHLH1 may be regarded as a new candidate gene for POI.
研究中国和塞尔维亚原发性卵巢功能不全(POI)患者中是否存在SOHLH1基因变异。
病例对照基因研究。
大学医院。
共364名中国汉族和197名塞尔维亚非综合征性POI女性以及种族匹配的对照。
无。
SOHLH1基因测序。
我们在561名POI女性队列中发现了10种新的杂合变异,但在600名种族匹配的对照中未发现。统计和生物信息学分析表明,中国POI病例中的8种变异中有3种可能致病。它们包括两个错义变异(p.Ser317Phe和p.Glu376Lys),可能分别改变SOHLH1作为转录因子的蛋白活性,以及一个位于SOHLH1基因3'非翻译区的变异(c.*118C>T),可能产生一个新的微小RNA hsa-miR-888-5p结合位点。塞尔维亚POI病例中的两个变异均为同义变异,未发现错义变异。一些已知单核苷酸多态性的等位基因频率在中国人和塞尔维亚人的患者与对照之间在统计学上有显著差异。
我们的结果表明,SOHLH1可被视为POI的一个新候选基因。